FOSTER CITY, Calif. & SALT LAKE CITY--(BUSINESS WIRE)--Oct. 26, 2005--Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced the contribution of more than 400,000 PCR primer-pair designs for nearly 16,000 human genes for detection of DNA sequence variants associated with disease and other phenotypes. The primer sequences will be made available through a new Probe Database developed by the National Center for Biotechnology Information (NCBI).
